Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier.

A new generation of drug delivery systems based on heparin-poly(isobutylcyanoacrylate) copolymers has been developed to carry hemoglobin. These copolymers spontaneously form, in water, nanoparticles with a ciliated surface of heparin. These nanoparticles maintain the heparin antithrombotic properties and inhibit complement activation. One ml of nanoparticle suspension can be loaded with up to 2.1mg of hemoglobin, which preserves its ligand binding capacity. This work constitutes the first demonstration of hemoglobin loaded on nanoparticle surface, rather than being encapsulated. With a size of 100 nm, these drug delivery systems make suitable tools in the treatment of thrombosis oxygen deprived pathologies.

[1]  P. Couvreur,et al.  Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles , 1992, Investigational New Drugs.

[2]  P. Legendre,et al.  Binding of Heparin Fractions to von Willebrand Factor: Effect of Molecular Weight and Affinity for Antithrombin III , 1994, Thrombosis and Haemostasis.

[3]  R. Williams,et al.  A convenient chromatographic method for the preparation of human hemoglobin. , 1973, Analytical biochemistry.

[4]  P. Couvreur,et al.  Design of folic acid-conjugated nanoparticles for drug targeting. , 2000, Journal of pharmaceutical sciences.

[5]  A. J. Khopade,et al.  Development of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer. , 2002, International journal of pharmaceutics.

[6]  P. Couvreur,et al.  Polymeric Micro- and Nanoparticles as Drug Carriers , 2001 .

[7]  D. Drabkin,et al.  SPECTROPHOTOMETRIC STUDIES: SPECTROPHOTOMETRIC CONSTANT FOR COMMON HAEMOGLOBIN DERIVATIVES IN HUMAN, DOG AND RABBIT BLOOD , 1932 .

[8]  M. Brandl,et al.  Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: vesicle characterization and in vivo behaviour. , 1994, Biochimica et biophysica acta.

[9]  P. Couvreur,et al.  Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties , 1979, The Journal of pharmacy and pharmacology.

[10]  S. Dumitriu.  Polysaccharides as Biomaterials , 2001 .

[11]  Patrick Couvreur,et al.  Pharmacokinetics and Distribution of a Biodegradable Drug-carrier , 1983 .

[12]  J. Olson,et al.  Myoglobin as a model system for designing heme protein based blood substitutes. , 2002, Biophysical chemistry.

[13]  M. Marden,et al.  T-state hemoglobin with four ligands bound. , 1988, Biochemistry.

[14]  P. Couvreur,et al.  Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[15]  P. Buehler,et al.  Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers. , 2000, Advanced drug delivery reviews.

[16]  T. Chang,et al.  Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation. , 2000, Advanced drug delivery reviews.

[17]  C. Passirani,et al.  Long-Circulating Nanopartides Bearing Heparin or Dextran Covalently Bound to Poly(Methyl Methacrylate) , 1998, Pharmaceutical Research.